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Involvement of FADD and caspase-8 signalling in detachment-
induced apoptosis
Marjatta Rytömaa, L. Miguel Martins and Julian Downward
Detachment of most untransformed adherent cells from
the extracellular matrix promotes apoptosis, in a
process termed anoikis [1,2]. The death signalling
mechanisms involved in this process are not known,
although adhesion or transformation by ras oncogenes
have been shown to protect epithelial cells from
apoptosis through activation of phosphatidylinositol
3-kinase and protein kinase B (PKB/Akt) [3]. Here we
show that detachment-induced apoptosis (anoikis) is
blocked by the expression of a dominant-negative form
of FAS-associated death domain protein (FADD) in a
number of untransformed epithelial cell lines. Because
the soluble extracellular domains of the death
receptors CD95, DR4 and DR5 failed to block anoikis,
we conclude that ligand-dependent activation of these
death receptors is not involved in this process.
Detachment induced strong activation of caspase 8 and
caspase 3. Detachment-induced caspase-8 activation
did not require the function of downstream caspases
but was blocked by overexpression of the anti-
apoptotic proteins Bcl-2 or Bcl-XL. We propose that
caspase-8 activation is the initiating event in anoikis,
which is subsequently subject to a positive-feedback
loop involving mitochondrial events. 
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Results and discussion
Death receptors and their associated adaptors, such as
FADD, and caspases, such as caspase 8, have been impli-
cated in diverse forms of apoptosis (reviewed in [4]). In
order to investigate the possible involvement of death-
receptor-induced signalling in anoikis, we used a domi-
nant-negative form of FADD (dnFADD), which contains
the death domain but not the death-effector domain. As
death domains are able to self-associate, dnFADD was
able to interact with other death-domain-containing pro-
teins but was unable to activate caspase 8. Madin-Darby
canine kidney (MDCK) cells were transfected with the
dnFADD expression construct [5] and a number of
stable cell lines generated. Following detachment from
extracellular matrix for 8 hours, five different clones
expressing dnFADD were all protected from apoptosis,
as measured using a DNA-fragmentation enzyme-linked
immunoabsorption assay (ELISA) (Figure 1a). As DNA
fragmentation does not necessarily correlate with apopto-
sis, these results were verified by staining for annexin V,
which indicates the exposure of phosphatidylserine at
the outer leaflet of the plasma membrane, an event char-
acteristic of early apoptotic cells. The percentage of cells
Figure 1
Stable expression of dnFADD inhibits anoikis. (a) Apoptosis in five
clones (c-2, c-4–6, c-9) of MDCK cells expressing dnFADD was
followed by DNA-fragmentation ELISA after cells had been kept in
suspension for 8 h. Cells that remained attached to the matrix were
used as a control. The percentage of annexin-V-positive cells was
determined by fluorescence-activated cell sorter (FACS) analysis. ND,
not determined. (b) HaCaT cells stably expressing GFP or
GFP–dnFADD were immunostained using phycoerythrin-conjugated
Annexin-V (annexin-V–PE). Attached cells, unshaded curves; detached
cells, shaded curves. Cells were kept in suspension for 16 h before
FACS analysis. 
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with annexin-V-positive staining is shown in Figure 1a. A
similar inhibition of anoikis was seen in the normal
immortalised human keratinocyte cell line HaCaT
expressing the death domain of FADD fused to GFP
(GFP–dnFADD) (Figure 1b).
The inhibition of anoikis by dnFADD raised the possi-
bility that death-receptor signalling could be involved in
this process. The normal immortalised human breast
epithelial cell line MCF-10A undergoes both CD95-
induced and detachment-induced apoptosis (Figure 2a).
To study the possible involvement of CD95 ligand
(CD95L) in anoikis, we used the soluble recombinant
CD95 extracellular domain fused to the immunoglobulin
Fc domain (CD95–Fc), which inhibits apoptosis by
acting as a soluble decoy receptor [6]. As expected,
CD95–Fc was able to block apoptosis induced by an
anti-CD95 antibody. CD95–Fc failed to protect the cells
from anoikis (Figure 2a), however, suggesting that
CD95L engagement of CD95 is not required for this
form of cell death. To further investigate the involvement
of other death receptors in anoikis, we studied the effects
of tumour necrosis factor (TNF)-related apoptosis-
inducing ligand (TRAIL) receptors-1 and -2 (also known
as DR4 and DR5, respectively). Soluble recombinant
DR4 and DR5 extracellular domains fused to
immunoglobulin Fc (DR4–Fc and DR5–Fc, respec-
tively) were similar to CD95–Fc in that they were not
able to block anoikis in MCF-10A cells (Figure 2b),
although they did prevent TRAIL-induced apoptosis.
Similar results were seen in MDCK cells, although in
these cells, TRAIL required the inhibition of protein
synthesis by cycloheximide to induce apoptosis (see
Supplementary material).
We conclude that any possible involvement of death
receptor pathways in anoikis suggested by the effects of
dnFADD is independent of CD95L and TRAIL inter-
actions with their receptors. This does not, however, rule
out the possibility of ligand-independent activation of
these receptors, because CD95–Fc, DR4–Fc, and
DR5–Fc are only able to block ligand-mediated receptor
activation. In addition, TNFα was not able to induce
death in MCF-10A or MDCK cells in the presence or
absence of cycloheximide, suggesting that the TNF
receptor is unlikely to be involved in anoikis (data not
shown). At present, we cannot rule out the possibility
that detachment induces activation of CD95 or other
death receptors in a ligand-independent manner. It is
also possible that other death receptors, such as DR3 or
DR6, could be involved, in either a ligand-dependent or
ligand-independent manner.
Activation of CD95 leads to the formation of a multi-
protein death-inducing signalling complex (DISC) to
which pro-caspase-8 is recruited and activated [4]. When
MCF-10A cells were kept in suspension or treated with an
anti-CD95 antibody the activated cleavage product of
caspase 8 (p20) became visible by western blotting
(Figure 2c). But, if the cells were simultaneously treated
with 100 µM of the broad specificity caspase inhibitor
z-VAD-fmk, caspase 8 was not activated. This correlated
with its effect on DNA fragmentation (Figure 2a). Soluble
CD95–Fc blocked caspase-8 activation induced by the
anti-CD95 antibody but not that induced by detachment
(Figure 2c). When apoptosis of MCF-10A cells was
induced by treatment with TRAIL, a similar caspase-8
activation was observed (Figure 2d). Furthermore,
DR4–Fc and DR5–Fc were able to block the TRAIL-
induced activation of caspase 8. TRAIL-induced apopto-
sis and caspase-8 activation were also inhibited by
z-VAD-fmk. DR4–Fc and DR5–Fc had no effect on
detachment-induced activation of caspase 8, however,
which is similar to their lack of effect on detachment-
induced DNA fragmentation (Figure 2b,d). Similar effects
were seen in MDCK cells treated with TRAIL plus
cycloheximide (see Supplementary material).
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Figure 2
Apoptosis and caspase-8 activation induced by detachment, an anti-
CD95 antibody or TRAIL. (a) MCF-10A cells were kept in suspension
(detached) or treated with 500 ng/ml anti-CD95 antibody (APO 1–3) for
24 h in a 1:1 mixture of DMEM and HAMS nutrient mixture F12
supplemented with 5% horse serum. In columns 3, 4, 6 and 7, cells were
simultaneously treated with either 100 µM z-VAD-fmk or 3 µg/ml soluble
recombinant CD95 (CD95–Fc). (b) MCF-10A cells were kept in
suspension or treated with 100 ng/ml TRAIL using the same conditions
as described in (a) except that some cells were simultaneously treated
with either 100 µM z-VAD-fmk or 100 ng/ml soluble recombinant
DR4–Fc or DR5–Fc. (c,d) Cells were treated as in (a,b) and the cleaved
p20 subunit (arrow) of activated caspase 8 was detected by
immunoblotting. (e) Detachment-induced activation of caspase 8 in wild-
type (WT) and dnFADD-expressing MDCK cells after 8 h in suspension. 
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To study the role of FADD in anoikis, we compared
caspase-8 activation in wild-type MDCK cells and cell
lines stably expressing dnFADD. No detachment-
induced caspase-8 activation was seen in cells expressing
dnFADD, even though caspase-8 activation was readily
detectable in wild-type MDCK cells (Figure 2e). In
wild-type MDCK cells, the activation of caspase 8 was
visible 3–4 hours after detachment (data not shown). To
verify the activation of caspase 8, another antibody was
used to detect the first cleavage product of caspase 8 (see
Supplementary material). 
To study the role of FADD in the regulation of down-
stream, or executioner, caspases, we measured the
caspase-3-like activity in MDCK cell lysates by monitor-
ing cleavage of the fluorescent caspase-3 substrate
z-DEVD-AFC. No DEVDase activity was seen in
attached wild-type MDCK cells, but when cells were
detached from matrix and kept in suspension for 8 hours,
strong DEVDase activity was seen (Figure 3a). In con-
trast, cells stably expressing dnFADD did not have any
DEVDase activity under these conditions. On the basis
of these observations, we conclude that dnFADD acts
upstream of the executioner caspases in the death-sig-
nalling cascade. To measure the caspase-3-like activity
in intact live HaCaT cells, a cell-permeable fluorescent
caspase-3 substrate, PhiPhiLux-G2D2, was used. As in
MDCK cells, detachment induced activation of caspase-
3 in HaCaT cells and this activation was blocked by
GFP–dnFADD (Figure 3b). Similarly, caspase 7, like
caspase-3, was activated in MDCK cells after detach-
ment (see Supplementary material).
Although the data presented above could be interpreted
to mean that caspase-8 activation is an initiating event in
anoikis, it is also possible that the strong caspase-8 activa-
tion observed occurs as a result of positive feedback from
the apoptosome [4] and thus may not initiate apoptosis,
but rather might be a consequence of it. In order to inves-
tigate this possibility, we examined whether caspase-8
activation following detachment from matrix depends on
the activation of other caspases. 
Treatment of MDCK cells with 100 µM z-VAD-fmk, a
general inhibitor of caspases, resulted in a complete inhi-
bition of anoikis (Figure 4c), and also of detachment-
induced caspase-8 and caspase-3 activation
(Figure 4a,b). When MDCK cells were treated with
10 µM z-DEVD-fmk, an inhibitor with partial selectivity
for caspase 3, however, detachment-induced caspase-3
activation was totally blocked (Figure 4b), as was detach-
ment-induced apoptosis (Figure 4c), but considerable
caspase-8 activation still occurred (Figure 4a). Thus,
caspase-8 activation can occur independently of caspase-
3 activation following detachment from matrix, and thus
does not rely on the activation of this downstream exe-
cutioner caspase. Another possibility is that caspase 8 can
be cleaved by caspase 9, so the role of caspase 9 in the
activation of caspase 8 was studied. An inhibitor with
partial selectivity for caspase-9, z-LEHD-fmk, did not
affect detachment-induced caspase-8 activation (Figure 4a),
although it inhibited DNA fragmentation (Figure 4c). By
contrast, a caspase-8 inhibitor, z-IETD-fmk, blocked
both detachment-induced apoptosis (Figure 4c) and
caspase-8 activation (Figure 4a). As neither caspase 3 nor
caspase 9 appear to be required for caspase-8 activation
following detachment from matrix, it seems likely that
auto-proteolytic caspase-8 activation is an initiating
event in anoikis.
Although the strong activation of caspase-8 detected after
cell detachment appears not to require caspase-3 or
caspase-9 activity, it could be potentiated by positive
feedback involving other post-mitochondrial events. As
such events should be inhibited by protection of mito-
chondria from disruption, the effect of overexpressing
Bcl-2 and Bcl-XL was tested on the induction of apoptosis
and caspase-8 activation following detachment from extra-
cellular matrix. As shown in Figure 4d, overexpression of
Bcl-2 or Bcl-XL protected MDCK cells from anoikis, with
Bcl-XL being more effective than Bcl-2. Similarly, Bcl-XL,
and to a lesser extent Bcl-2, also inhibited detachment-
induced activation of caspase-8 (Figure 4e). Therefore, it
is possible that the activation of caspase 8 seen on detach-
ment is reinforced by mitochondrial damage, perhaps
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Figure 3
Detachment-induced activation of caspase 3 in MDCK and HaCaT
cells. (a) The presence of caspase-3-like activity in cytoplasmic
extracts of wild-type (WT) and dnFADD-expressing MDCK cells was
measured after 8 h in suspension. The cleavage of a fluorescent
substrate z-DEVD-AFC (DEVD) was followed by measuring the
increase in the fluorescence intensity. For comparison, the activity in
attached wild-type cells is shown. (b) Detachment-induced caspase-3
activation in HaCaT cells expressing GFP (upper panel) or
GFP–dnFADD (lower panel). Caspase-3-like activity was measured in
attached cells (unshaded curve) or after keeping the cells in
suspension for 16 h (shaded curve) by FACS analysis after incubation
with a cell-permeable fluorescent substrate, PhiPhiLux-G2D2.
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through caspase-8 cleavage of the Bcl-2 antagonist BID
[7,8]. Anoikis could thus be characterised as a type II
death receptor signalling pathway [9]. Alternatively, it is
possible that Bcl-2 or Bcl-XL inhibit caspase-8 activation
through a mechanism that is independent of effects on the
mitochondria: direct interaction of Bcl-XL with caspase-8
has been reported in overexpression systems [10], but no
evidence for this could be found in any of the cells used
here (data not shown). Bcl-2 overexpression has also been
shown to inhibit formation of the DISC in Jurkat cells (a
type II cell line) [11], suggesting the possible involvement
of these anti-apoptotic proteins in the earliest death 
signalling events. 
In summary, we propose that detachment of epithelial
cells from extracellular matrix induces apoptosis through a
pathway involving proteins sequestered by the death
domain of FADD, but without the involvement of known
ligands for death receptors. Detachment results in
caspase-8 activation as an initiating event that leads to the
triggering of mitochondrial dysfunction and executioner
caspase activation, which result in cell death by apoptosis.
A positive-feedback loop from the mitochondria may be
involved as Bcl-XL overexpression inhibits detachment-
induced caspase-8 activation. 
Supplementary material
Figures showing the effects of apoptosis-inducing agents on the activa-
tion of caspases 8 and 7 in MDCK cells,  and additional methodological
details are available at http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Effects of the caspase inhibitors Bcl-2 and
Bcl-XL on detachment-induced apoptosis and
caspase activation in MDCK cells. Cells were
kept in suspension for 8 h before lysis. Either
100 µM z-VAD-fmk (z-VAD), 10 µM z-IETD-
fmk (z-IETD), 10 µM z-LEHD-fmk (z-LEHD), 
or 10 µM z-DEVD-fmk (z-DEVD) were added
when cells were detached. (a) Caspase-8
activation was detected by immunoblotting.
(b) Affinity labelling of activated caspases
with biotin-YVAD-aomk. Control, purified
caspases from HL60 cells labelled with 
Z-EK(biotin)D-aomk (see Supplementary
material). (c) Apoptosis measured using
DNA-fragmentation ELISA. (d) DNA
fragmentation and (e) caspase-8 activation in
MDCK cells expressing Bcl-2 or Bcl-XL after
8 h in suspension.
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Supplementary materials and methods
Materials
Caspase inhibitors were from Calbiochem. PhiPhiLux-G2D2 was from
Oncoimmunin. Annexin-V–PE, the anti-CD95 antibody (clone APO 1–3),
soluble recombinant CD95 (CD95–Fc) and soluble human recombinant
TRAIL were from Alexis. Soluble DR4 (DR4–Fc) and DR5 (DR5–Fc)
were from R&D Systems. 
Expression vectors
Dominant-negative FADD (dnFADD) was kindly provided by Vishva
Dixit (Genentech). Bcl-2 and Bcl-XL were cloned into pBabe-puro and
pBabe-hygro, respectively, and GFP-dnFADD was cloned into pEGFP.
Cell lines
To generate MDCK cells stably expressing dnFADD, and HaCaT cells
stably expressing GFP–dnFADD or GFP alone, cells were transfected
by lipofection according to manufacturer's instructions (Lipofecta-
mine, GibcoBRL). To generate pools of MDCK cells stably expressing
Bcl-2 or Bcl-XL, MDCK cells expressing the ecotropic retrovirus
receptor were infected with ecotropic viruses according to Serrano et
al. [S1]. The expression of protein was assessed by western blotting
of cell lysates.
DNA fragmentation assay
Subconfluent MDCK cells were detached and assayed as described
previously [S2]. MCF-10A cells were treated in the same way except
Supplementary material
Figure S1
Apoptosis and caspase-8 activation induced by cell–matrix
detachment or TRAIL in MDCK cells. DNA-fragmentation ELISA was
performed 8 h after detachment or after various treatments. (a) MDCK
cells were kept in suspension or treated with TRAIL and/or
cycloheximde (CHx) in DMEM supplemented with 10% fetal bovine
serum (FBS) for 8 h. Either 100 µM z-VAD-fmk (z-VAD) or 100 ng/ml
soluble recombinant DR4 (DR4–Fc) or DR5 (DR5–Fc) were added
when cells were detached or treated with 5 µg/ml cycloheximide and
100 ng/ml TRAIL. The increase in DNA fragmentation was calculated
by comparing the absorbance of detached cells to the absorbance of
wild-type cells maintained on the tissue culture dish. (b) Cells were
treated as in (a), lysed with SDS sample buffer, and proteins separated
by SDS–PAGE. Caspase 8 was detected by immunoblotting. The
arrow indicates the cleaved p20 subunit of activated caspase 8.
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Figure S2
Detachment-induced activation of caspase 8 and caspase 7 in MDCK
cells. (a) A partially cleaved form of caspase 8 in wild-type MDCK cells
was detected by an antibody that specifically recognises this form of
caspase 8. Cells were lysed with SDS sample buffer and proteins
separated by SDS–PAGE. Caspase 8 was detected by immunoblotting.
(b) Detachment-induced activation of caspase 7 in MDCK cells was
determined by immunoblotting using an anti-caspase-7 antibody.
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resuspension was in a 1:1 mixture of DMEM and HAMS nutrient
mixture F12 supplemented with 5% horse serum. DNA-fragmentation
ELISA was performed using the Cell Death Detection ELISA kit
(Boehringer Mannheim) according to the manufacturer’s instructions.
The results represent at least three independent experiments and the
increase in DNA fragmentation was calculated by comparing the
absorbance of detached or treated cells to the absorbance of wild-type
cells maintained on the tissue culture dish.
Caspase-7 and caspase-8 activation
After the indicated treatment, cells were lysed with sample buffer
and proteins were separated by 12% SDS–PAGE. Immunoblotting
was performed with an anti-caspase-7 (PharMingen) or anti-
caspase-8 (C-20, Santa Cruz Biotechnology) antibody, followed by
enhanced chemiluminescence (ECL) according to the manufactur-
er’s instructions (Amersham).
Caspase-3 activation
For the fluorometric caspase assay, 5 × 105 cells were analysed as
described previously [S3]. Affinity labelling of activated caspases
was performed as previously described by Faleiro et al. [S4] using
the broad specificity caspase substrates biotin–YVAD–aomk and Z-
EK(biotin)D-aomk; these bind covalently to caspase active sites,
introducing a biotin tag. To measure the intracellular caspase-3-like
activity in HaCaT cells, the cells were trypsinized and washed with
serum-containing medium. The cell pellet was resuspended with
80 µl of 10 µM PhiPhiLux-G2D2 substrate solution (OncoImmunin)
in RPMI supplemented with 5% FBS and processed according to
manufacturer’s instructions.
Annexin V staining
To measure apoptosis by phosphatidylserine exposure, 106 cells were
treated as indicated in the text. Cells were trypsinized, washed with
serum-containing medium, and with 2 ml of Hepes buffer (10 mM
Hepes–NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). The cell pellet
was resuspended with 1 ml Hepes buffer and 5 µl of Annexin-V–PE
(Alexis) was added. After incubation for 30 min at room temperature,
avoiding direct light, the samples were analysed by FACS. 
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